Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Taiho Pharmaceutical and Phost’in Therapeutics Announce Licence Agreement on GnT-V Inhibitor PhOx430
Tuesday, August 29, 2023Taiho Pharmaceutical and Phostin Therapeutics have entered into an option and licence agreement that outlines their collaboration regarding the development and commercialisation of a novel compound named PhOx
Specialised Therapeutics Acquires Commercialisation Rights for New Motor Neuron Disease Therapy
Monday, August 28, 2023Specialised Therapeutics has recently announced a collaboration with Treeway to bring a new therapy TW to Australia and New Zealand for the treatment of Amyotrophic Lateral Sclerosis ALS which is the most common form of Motor Neurone Disease MND
ImmunoGen Collaborates with Takeda Pharmaceuticals to Develop and Commercialise ELAHERE® in Japan
Monday, August 28, 2023ImmunoGen announced that it has entered into collaboration with Takeda Pharmaceuticals for the development and commercialisation of ELAHERE mirvetuximab soravtansinegynx in Japan
Radiopharm Theranostics Expands Supply Agreement With Terthera For Terbium-161 Isotope Use In Prostate Cancer
Friday, August 25, 2023Radiopharm Theranostics announced an expanded agreement with TerThera to supply Terbium Tb for treatment of advanced prostate cancer
AstraZeneca Announces Approval of Lynparza in Japan
Friday, August 25, 2023AstraZeneca and MSDs Lynparza olaparib in combination with abiraterone and prednisolone has received approval in Japan for the treatment of adult patients who have BRCAmutated BRCAm castrationresistant prostate cancer with distant metastasis mCRPC
Pfizer and Astellas Pharma Announce FDA Priority Review for XTANDI®
Thursday, August 24, 2023Pfizer and Astellas Pharma have recently announced that the US Food and Drug Administration FDA has accepted the supplemental new drug application sNDA for XTANDI enzalutamide
Daiichi Sankyo Announces Approval of ENHERTU® in Japan
Thursday, August 24, 2023Daiichi Sankyo has received approval for the use of ENHERTU trastuzumab deruxtecan in the treatment of adult patients with unresectable advanced or recurrent nonsmall cell lung cancer NSCLC who have HER ERBB mutations and have experienced disease pro...
SK bioscience and Vaxxas Enter Joint Development Agreement
Thursday, August 24, 2023SK bioscience and Vaxxas have forged a joint development agreement The collaboration represents a significant advancement in the field of vaccine delivery
Sanyou Biopharmaceuticals and Sinorda Biomedicine Enter into Agreement
Wednesday, August 23, 2023Sanyou Biopharmaceuticals and Sinorda Biomedicine have recently entered into a strategic cooperation agreement to drive their innovative bispecific antibody drug project
MGI Announces Partnership with NGeneBio
Wednesday, August 23, 2023MGI and NGeneBio have recently entered into a memorandum of understanding MOU with the aim of expanding the global availability of NGeneBios cancer testing products
